Case Report

Accepted on 24 Dec 2024

Overlapping syndrome of MOG-IgG associated optic neuritis and autoimmune encephalitis with co-existence of anti-NMDAR and anti-GABABR antibodies

in Multiple Sclerosis and Neuroimmunology

Zhujun Mei
Jingguo Wang
Junling Wang
Xiaoni Liu
Bo Deng
Wenbo Yang
Xiang Zhang
Xiangjun Chen
Hai Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461024

Case Report

Accepted on 23 Dec 2024

Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: A report of 2 cases

in Multiple Sclerosis and Neuroimmunology

Tianying Ma
Ying Zhu
Ruixia Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497398

Opinion

Published on 20 Dec 2024

MiR-25802: a potential target for treating Alzheimer’s disease by regulating neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Kaiyue Zhao
Zixuan Li
Li Zeng
Zhongdi Cai
Rui Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1524432

225 views

Review

Published on 20 Dec 2024

Research progress on digestive disorders following traumatic brain injury

in Multiple Sclerosis and Neuroimmunology

Yongshuang Lin
Chengshan Hou
Cheng Wang
Rui Chen
Yunzhong Zhu
Qing Zhou
Binbin Shao
Yi Huang
Shun Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1524495

132 views

Original Research

Accepted on 19 Dec 2024

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

J.Q. Alida Chen
Dennis Daniël Wever
Niamh McNamara
Morjana Bourik
Joost Smolders
Jörg Hamann
Inge Huitinga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522381

107 views

Mini Review

Accepted on 19 Dec 2024

Spatial distribution-based progression of spinal cord injury pathology: a key role for neuroimmune cells

in Multiple Sclerosis and Neuroimmunology

Jian Li
Xiaolei Zhai
Chaochun Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505755

Case Report

Accepted on 19 Dec 2024

Severe Guillain-Barré Syndrome with Concurrent Optic Neuritis in a Pediatric Patient: A Case Report

in Multiple Sclerosis and Neuroimmunology

Xue 辛
Yingcun Bao
Yakun Yu
Qun Li
Mei Liu
Xiaoling Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1517943

Correction

Published on 19 Dec 2024

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Fernando Rodríguez-Jorge
José Ignacio Fernández-Velasco
Noelia Villarrubia
Julia Gracia-Gil
Eva Fernández
Virginia Meca-Lallana
Carolina Díaz-Pérez
Susana Sainz de la Maza
Eva María Pacheco
Ana Quiroga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1535051

Original Research

Accepted on 18 Dec 2024

Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression

in Multiple Sclerosis and Neuroimmunology

Stefano Ruberto
María Immaculada Dominguez-Mozo
Angel Garcia Martínez
Davide Cossu
Leonardo Antonio Sechi
Roberto Alvarez-Lafuente

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505239

Mini Review

Accepted on 18 Dec 2024

The immunological bases of alemtuzumab as inductiontherapies in pediatric-onset multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Marco Puthenparampil
Marta Gaggiola
Francesca Rinaldi
Margherita Nosadini
Stefano Sartori
Paola Perini
Paolo Gallo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1509987

Case Report

Published on 17 Dec 2024

Case report on anti-GQ1b antibody syndrome: initial symptoms of pupil palsy and periorbital pain

in Multiple Sclerosis and Neuroimmunology

Yang Du
Weidong Wang
Lili Zhang
Yuan Li
Xiang Chen
Hui Yang
Xin Ding

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474354

144 views

Original Research

Published on 17 Dec 2024

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Nicole Vasilenko
Maria P. Tieck
Tanja Michel
Sonja Schembecker
Patricia Schwarz
Anna Guenther
Christoph Ruschil
Sven Poli
Ulf Ziemann
Antje Giede-Jeppe

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487523

353 views

Original Research

Published on 17 Dec 2024

The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Femke Van Gaever
Fleur Mingneau
Sam Vanherle
Yasmine Driege
Mira Haegman
Elien Van Wonterghem
Junhua Xie
Roosmarijn E. Vandenbroucke
Jerome J. A. Hendriks
Rudi Beyaert

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500697

505 views

Original Research

Accepted on 16 Dec 2024

Rat Models of Postintracerebral Hemorrhage Pneumonia Induced by Nasal Inoculation with Klebsiella pneumoniae or Intratracheal Inoculation with LPS

in Multiple Sclerosis and Neuroimmunology

Ruihua Wang
Changlian Gan
Rui Mao
Yang Chen
Ru Yan
Geng Li
Tianqin Xiong
Jianwen Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477902

Original Research

Accepted on 16 Dec 2024

Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course

in Multiple Sclerosis and Neuroimmunology

Elisabetta Zucchi
Federico Banchelli
Cecilia Simonini
Sara De Biasi
Ilaria Martinelli
GIULIA GIANFERRARI
Domenico Lo Tartaro
Andrea Cossarizza
Roberto D'Amico
Jessica Mandrioli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1508974

Original Research

Published on 16 Dec 2024

Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response

in Multiple Sclerosis and Neuroimmunology

Zuzana Jiraskova Zakostelska
Michal Kraus
Stepan Coufal
Petra Prochazkova
Zaneta Slavickova
Tomas Thon
Tomas Hrncir
Jakub Kreisinger
Klara Kostovcikova
Pavlina Kleinova

Frontiers in Immunology

doi 10.3389/fimmu.2024.1475126

269 views

Navigation group

Articles

Overlapping syndrome of MOG-IgG associated optic neuritis and autoimmune encephalitis with co-existence of anti-NMDAR and anti-GABABR antibodies

Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: A report of 2 cases

MiR-25802: a potential target for treating Alzheimer’s disease by regulating neuroinflammation

Research progress on digestive disorders following traumatic brain injury

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis

Spatial distribution-based progression of spinal cord injury pathology: a key role for neuroimmune cells

Severe Guillain-Barré Syndrome with Concurrent Optic Neuritis in a Pediatric Patient: A Case Report

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression

The immunological bases of alemtuzumab as inductiontherapies in pediatric-onset multiple sclerosis

Case report on anti-GQ1b antibody syndrome: initial symptoms of pupil palsy and periorbital pain

In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis

The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis

Rat Models of Postintracerebral Hemorrhage Pneumonia Induced by Nasal Inoculation with Klebsiella pneumoniae or Intratracheal Inoculation with LPS

Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course

Lysate of Parabacteroides distasonis prevents severe forms of experimental autoimmune encephalomyelitis by modulating the priming of T cell response